首页 > 最新文献

Other Topics最新文献

英文 中文
Abstract P070: The safety and efficacy of Durvalumab and Paclitaxel combination in metastatic triple-negative breast cancer: An open-label phase I/II trial with 2-years follow-up P070: Durvalumab和紫杉醇联合治疗转移性三阴性乳腺癌的安全性和有效性:一项为期2年随访的开放标签I/II期试验
Other Topics
Pub Date : 2022-01-01 DOI: 10.1158/2326-6074.tumimm21-p070
H. Ghebeh, Adher Al-Sayed, Kauser Suleman, Riham Eiada, A. Tulbah, T. Al-Tweigeri
{"title":"Abstract P070: The safety and efficacy of Durvalumab and Paclitaxel combination in metastatic triple-negative breast cancer: An open-label phase I/II trial with 2-years follow-up","authors":"H. Ghebeh, Adher Al-Sayed, Kauser Suleman, Riham Eiada, A. Tulbah, T. Al-Tweigeri","doi":"10.1158/2326-6074.tumimm21-p070","DOIUrl":"https://doi.org/10.1158/2326-6074.tumimm21-p070","url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123836224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract P073: Gut microbiota shift in melanoma patients undergoing immunotherapy is associated with clinical response P073:接受免疫治疗的黑色素瘤患者的肠道微生物群变化与临床反应相关
Other Topics
Pub Date : 2022-01-01 DOI: 10.1158/2326-6074.tumimm21-p073
A. D. Macandog, C. Catozzi, Ester Cassano, S. Gandini, P. Ferrucci, E. Cocorocchio, T. Manzo, L. Nezi
{"title":"Abstract P073: Gut microbiota shift in melanoma patients undergoing immunotherapy is associated with clinical response","authors":"A. D. Macandog, C. Catozzi, Ester Cassano, S. Gandini, P. Ferrucci, E. Cocorocchio, T. Manzo, L. Nezi","doi":"10.1158/2326-6074.tumimm21-p073","DOIUrl":"https://doi.org/10.1158/2326-6074.tumimm21-p073","url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"130 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115892938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Abstract P071: Gemcitabine augments HLA class I expression in pancreatic cancer cells through alterations in transcript production and surface stability 摘要:吉西他滨通过改变转录产物和表面稳定性来增加胰腺癌细胞中HLA I类的表达
Other Topics
Pub Date : 2022-01-01 DOI: 10.1158/2326-6074.tumimm21-p071
Alaina C. Larson, S. Knoche, J. Solheim
{"title":"Abstract P071: Gemcitabine augments HLA class I expression in pancreatic cancer cells through alterations in transcript production and surface stability","authors":"Alaina C. Larson, S. Knoche, J. Solheim","doi":"10.1158/2326-6074.tumimm21-p071","DOIUrl":"https://doi.org/10.1158/2326-6074.tumimm21-p071","url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122874725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract P067: Current status of regulatory-approved immunotherapies in Saudi Arabia P067:沙特阿拉伯监管部门批准的免疫疗法的现状
Other Topics
Pub Date : 2022-01-01 DOI: 10.1158/2326-6074.tumimm21-p067
R. Ajina
{"title":"Abstract P067: Current status of regulatory-approved immunotherapies in Saudi Arabia","authors":"R. Ajina","doi":"10.1158/2326-6074.tumimm21-p067","DOIUrl":"https://doi.org/10.1158/2326-6074.tumimm21-p067","url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115941774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract P076: Humanized anti-αvβ3 antibody engineered to selectively promote macrophage-mediated cancer cell death P076:人源化抗αvβ3抗体选择性促进巨噬细胞介导的癌细胞死亡
Other Topics
Pub Date : 2022-01-01 DOI: 10.1158/2326-6074.tumimm21-p076
Hiromi I Wettersten, Ryan M. Shepard, S. Weis, D. Cheresh
{"title":"Abstract P076: Humanized anti-αvβ3 antibody engineered to selectively promote macrophage-mediated cancer cell death","authors":"Hiromi I Wettersten, Ryan M. Shepard, S. Weis, D. Cheresh","doi":"10.1158/2326-6074.tumimm21-p076","DOIUrl":"https://doi.org/10.1158/2326-6074.tumimm21-p076","url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"142 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121898520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract P075: NTX-1088, a potent first-in-class, anti-PVR mAb, restores expression and function of DNAM1 for optimal DNAM1-mediated antitumor immunity P075: NTX-1088是一种有效的抗pvr单抗，可恢复DNAM1的表达和功能，从而获得最佳的DNAM1介导的抗肿瘤免疫
Other Topics
Pub Date : 2022-01-01 DOI: 10.1158/2326-6074.tumimm21-p075
Pini Tsukerman, A. Atieh, A. Obeidat, K. Paz, G. Cinamon, T. Roviš, Paola Kučan Brlić, L. Hiršl, S. Jonjić, O. Mandelboim
{"title":"Abstract P075: NTX-1088, a potent first-in-class, anti-PVR mAb, restores expression and function of DNAM1 for optimal DNAM1-mediated antitumor immunity","authors":"Pini Tsukerman, A. Atieh, A. Obeidat, K. Paz, G. Cinamon, T. Roviš, Paola Kučan Brlić, L. Hiršl, S. Jonjić, O. Mandelboim","doi":"10.1158/2326-6074.tumimm21-p075","DOIUrl":"https://doi.org/10.1158/2326-6074.tumimm21-p075","url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"163 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121403092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract P077: Composition of CD4 T cell subsets and impact on tumor growth control across mouse syngeneic tumor models P077:小鼠同基因肿瘤模型中CD4 T细胞亚群的组成及其对肿瘤生长控制的影响
Other Topics
Pub Date : 2022-01-01 DOI: 10.1158/2326-6074.tumimm21-p077
Chunxiao Xu, Lindsay M Webb, Sireesha Yalavarthi, C. Bourin, J. Moisan
{"title":"Abstract P077: Composition of CD4 T cell subsets and impact on tumor growth control across mouse syngeneic tumor models","authors":"Chunxiao Xu, Lindsay M Webb, Sireesha Yalavarthi, C. Bourin, J. Moisan","doi":"10.1158/2326-6074.tumimm21-p077","DOIUrl":"https://doi.org/10.1158/2326-6074.tumimm21-p077","url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125245007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract P066: Prognostic and predictive value of pre-treatment T-Cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy P066:治疗前t细胞受体(TCR)库在单药免疫治疗非小细胞肺癌(NSCLC)患者中的预后和预测价值
Other Topics
Pub Date : 2022-01-01 DOI: 10.1158/2326-6074.tumimm21-p066
A. Abed, L. Calapre, S. Bowyer, M. Millward, E. Gray
{"title":"Abstract P066: Prognostic and predictive value of pre-treatment T-Cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy","authors":"A. Abed, L. Calapre, S. Bowyer, M. Millward, E. Gray","doi":"10.1158/2326-6074.tumimm21-p066","DOIUrl":"https://doi.org/10.1158/2326-6074.tumimm21-p066","url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123987867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract P069: Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence P069:基于多抗体和人工智能的CTLA-4在90种不同肿瘤实体中的半自动验证和定量
Other Topics
Pub Date : 2022-01-01 DOI: 10.1158/2326-6074.tumimm21-p069
D. Dum, Tjark L. C. Henke, T. Mandelkow, E. Bady, J. Raedler, R. Simon, G. Sauter, M. Lennartz, W. Wilczak, E. Burandt, S. Steurer, N. Blessin
{"title":"Abstract P069: Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence","authors":"D. Dum, Tjark L. C. Henke, T. Mandelkow, E. Bady, J. Raedler, R. Simon, G. Sauter, M. Lennartz, W. Wilczak, E. Burandt, S. Steurer, N. Blessin","doi":"10.1158/2326-6074.tumimm21-p069","DOIUrl":"https://doi.org/10.1158/2326-6074.tumimm21-p069","url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129832219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract P072: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) foster myeloid-derived suppressor cell-mediated tumor immune evasion in cholangiocarcinoma 肿瘤坏死因子相关凋亡诱导配体(TRAIL)在胆管癌中促进髓源性抑制细胞介导的肿瘤免疫逃避
Other Topics
Pub Date : 2022-01-01 DOI: 10.1158/2326-6074.tumimm21-p072
E. Loeuillard, Juan Wang, Jingchun Yang, Haidong Dong, G. Gores, S. Ilyas
{"title":"Abstract P072: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) foster myeloid-derived suppressor cell-mediated tumor immune evasion in cholangiocarcinoma","authors":"E. Loeuillard, Juan Wang, Jingchun Yang, Haidong Dong, G. Gores, S. Ilyas","doi":"10.1158/2326-6074.tumimm21-p072","DOIUrl":"https://doi.org/10.1158/2326-6074.tumimm21-p072","url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129010532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Other Topics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1